Monocyte-derived DCs (moDCs) have been implicated in the pathogenesis of autoimmunity, but the molecular pathways determining the differentiation potential of these cells remain unclear. Here, we report that microRNA-148a (miR-148a) serves as a critical regulator for moDC differentiation. First, miR-148a deficiency impaired the moDC development in vitro and in vivo. A mechanism study showed that MAFB, a transcription factor that hampers moDC differentiation, was a direct target of miR-148a. In addition, a promoter study identified that miR-148a could be transcriptionally induced by PU.1, which is crucial for moDC generation. miR-148a ablation eliminated the inhibition of PU.1 on MAFB. Furthermore, we found that miR-148a increased in monocytes from patients with psoriasis, and miR-148a deficiency or intradermal injection of antagomir-148a immensely alleviated the development of psoriasis-like symptoms in a psoriasis-like mouse model. Therefore, these results identify a pivotal role for the PU.1-miR-148a-MAFB circuit in moDC differentiation and suggest a potential therapeutic avenue for autoimmunity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205423PMC
http://dx.doi.org/10.1172/jci.insight.133721DOI Listing

Publication Analysis

Top Keywords

modc differentiation
12
differentiation potential
8
mir-148a deficiency
8
mir-148a
7
differentiation
5
modc
5
microrna-148a facilitates
4
facilitates inflammatory
4
inflammatory dendritic
4
dendritic cell
4

Similar Publications

Dendritic cells (DCs), the primary antigen-presenting cells, have traditionally been identified by CD103 molecules in rats, whereas mouse and human DCs are identified by CD11c molecules. However, this history does not preclude the existence of CD103 DCs in rats. To explore this possibility, we examined MHCII cells in rat spleen and thymus, identifying a novel population of CD103MHCIICD45RCD172a cells.

View Article and Find Full Text PDF

Background: Allergen-specific immunotherapy (AIT) is so far the only disease-modifying therapy for allergy, resulting in a long-lasting tolerance. However, the existing safety concerns and the need for more efficacious alternatives that shorten the duration of treatment have stimulated research into the development of novel alternatives. Some of these novel alternatives involve modifying allergens with molecules that target innate immunomodulatory receptors to suppress the immune activity of immune cells.

View Article and Find Full Text PDF
Article Synopsis
  • Penile squamous cell carcinoma (PSCC), mainly affecting poorer regions, has risk factors such as low socioeconomic status, phimosis, and HPV infection, but its immune response and treatment options are still unclear.
  • The study collected data from 30 PSCC patients (mostly HPV-positive) and 19 healthy donors to analyze immune cell behavior and utilize a tumor-mimicking environment created from HPV-positive tumor cultures.
  • Results indicated that HPV-positive tumors had fewer T lymphocytes and that dendritic cells in these patients were less mature and had lower activation compared to healthy controls, potentially affecting the immune response and disease progression.
View Article and Find Full Text PDF

New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells.

Cancer Immunol Immunother

November 2024

Associate Laboratory i4HB, NOVA School of Science and Technology, Institute for Health and Bioeconomy, Universidade NOVA de Lisboa, 2829-516, Caparica, Portugal.

Sialic acids at the cell surface of dendritic cells (DCs) play an important immunomodulatory role, and their manipulation enhances DC maturation, leading to heightened T cell activation. Particularly, at the molecular level, the increased stability of surface MHC-I molecules in monocyte-derived DCs (MoDCs) underpins an improved DC: T cell interaction. In this study, we focused on the impact of sialic acid remodelling by treatment with Clostridium perfringens sialidase on MoDCs' phenotypic and functional characteristics.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of 3D-printed polycaprolactone (PCL) scaffolds with varying stiffness and porosity on bone tissue engineering and the immune response involved in bone regeneration.
  • PCL scaffolds were produced using different techniques, revealing that high-temperature printing creates stiffer structures while low-temperature printing with NIPS results in more flexible, porous scaffolds.
  • Results indicated that porosity and stiffness of the scaffolds influence not only the proliferation and mineralization of bone marrow-derived stem cells but also the activation of immune cells, suggesting a complex relationship between scaffold properties and biological responses.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!